Pharmaceutical Composition for Headache Relief

Abstract

A pharmaceutical composition for headache relief combines a vasoconstricting agent, a pain relief agent, and a disposition altering agent for a three-pronged approach to headache or migraine relief.

What is claimed is: 
     
         1 . A pharmaceutical composition for headache relief comprises:
 a vasoconstricting agent;   a pain relief agent;   a disposition altering agent;   the vasocontricting agent being present at a range between 8-16 percent weight;   the pain relief agent being present at a range between 65-90 percent weight; and   the disposition altering agent being present at a range between 2-19 percent weight.   
     
     
         2 . The pharmaceutical composition for headache relief as claimed in  claim 1 , wherein the vasoconstricting agent is isometheptene mucate. 
     
     
         3 . The pharmaceutical composition for headache relief as claimed in  claim 1 , wherein the pain relief agent is acetaminophen. 
     
     
         4 . The pharmaceutical composition for headache relief as claimed in  claim 1 , wherein the disposition altering agent is caffeine. 
     
     
         5 . The pharmaceutical composition for headache relief as claimed in  claim 1 , wherein the disposition altering agent is dichloralphenazone. 
     
     
         6 . A pharmaceutical composition for headache relief comprises:
 a vasoconstricting agent;   a pain relief agent;   a disposition altering agent;   the vasocontricting agent being present at a range between 30-80 milligrams;   the pain relief agent being present at a range between 300-325 milligrams; and   the disposition altering agent being present at a range between 10-100 milligrams.   
     
     
         7 . The pharmaceutical composition for headache relief as claimed in  claim 6 , wherein the vasoconstricting agent is isometheptene mucate. 
     
     
         8 . The pharmaceutical composition for headache relief as claimed in  claim 6 , wherein the pain relief agent is acetaminophen. 
     
     
         9 . The pharmaceutical composition for headache relief as claimed in  claim 6 , wherein the disposition altering agent is caffeine. 
     
     
         10 . The pharmaceutical composition for headache relief as claimed in  claim 6 , wherein the disposition altering agent is dichloralphenazone. 
     
     
         11 . A pharmaceutical composition for headache relief comprises:
 a vasoconstricting agent;   a pain relief agent; and   a disposition altering agent.   
     
     
         12 . The pharmaceutical composition for headache relief as claimed in  claim 11  comprises about 65 milligrams of vasoconstricting agent, wherein the vasoconstricting agent is isometheptene mucate. 
     
     
         13 . The pharmaceutical composition for headache relief as claimed in  claim 11  comprises about 325 milligrams of pain relief agent, wherein the pain relief agent is acetaminophen. 
     
     
         14 . The pharmaceutical composition for headache relief as claimed in  claim 11  comprises about 20 milligrams of disposition altering agent, wherein the disposition altering agent is caffeine. 
     
     
         15 . The pharmaceutical composition for headache relief as claimed in  claim 11  comprises about 100 milligrams of disposition altering agent, wherein the disposition altering agent is dichloralphenazone.